Benzinga's Top Pre-Market NASDAQ Gainers (LXRX, ARMH, MVIS, GOLD)

Lexicon Pharmaceuticals Inc LXRX rose 41.72% to $2.14 in the pre-market session. LXRX reported positive results from clinical trial of LX4211 in Type 2 diabetes patients. ARM Holdings plc ARMH added 8.55% to $23.75 in the pre-market session. Microsoft Corp MSFT announced that next version of Windows operating system will work with the chips designed by ARMH. Microvision Inc MVIS moved up 3.60% to $2.30 in the pre-market session. MVIS shares have dipped 37.11% over the past 52 weeks, while the S&P 500 index has gained 12.26% in the same period. Randgold Resources Limited GOLD soared 3.42% to $80.84 in the pre-market trading. Analysts at Citigroup upgraded GOLD from “hold” to “buy.” Read more from Benzinga's Markets.